3 results
This pilot study sets out to assess stimulation-evoked PESP-BP using various stimulation protocols and to compare outcomes with PESP-BP by spontaneous ESB. Moreover, we aim to derive a stimulation protocol for PESP-BP assessment, which can be used…
Primary ObjectivePart1: To evaluate the safety and tolerability of intravenous (IV) administration of AL001 over up to 96 weeks in asymptomatic and symptomatic carriersof a granulin (GRN) mutation causative of frontotemporal dementia (FTD) and in…
The primary objective of this study is: Part 1: To evaluate the efficacy of AL001 compared with placebo as measured by CDR® plus NACC FTLD-SB.Part 2: To assess the long-term safety and tolerability of AL001 in participants who have completed 96…